Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials."

Circulation. 2015 Dec 1;132(22):e358. doi: 10.1161/CIRCULATIONAHA.115.018395.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fatty Acids, Omega-3 / therapeutic use*
  • Female
  • Fluorobenzenes / therapeutic use*
  • Heart Failure / drug therapy*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Natriuretic Peptide, Brain / blood*
  • Peptide Fragments / blood*
  • Pyrimidines / therapeutic use*
  • Stroke / etiology*
  • Sulfonamides / therapeutic use*

Substances

  • Fatty Acids, Omega-3
  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Peptide Fragments
  • Pyrimidines
  • Sulfonamides
  • Natriuretic Peptide, Brain